Warning message

ARCHIVED CONTENT: Persons using assistive technology may not be able to fully access information in this file. For assistance, please send an email to niaic@nia.nih.gov or call us at 1-800-222-2225.
About NIA

NACA Meeting: September 18-19, 2012

Legislative Update

NIH/NIA Appropriations and Authorization Legislation:

Continuing Resolution for FY 2013:

On July 31, 2012, Senator Harry Reid (D-NV), Senate Majority Leader, announced that he and Representative John Boehner (R-OH), Speaker of the House, had reached an agreement on a six-month Continuing Resolution for FY2013, which would be written during the August recess and voted on in September. The White House has signaled their concurrence with this proposal. Under this agreement, funding would be consistent with the $1.047 trillion level for fiscal 2013 set forth in last year’s Budget Control Act, and above the $1.028 trillion called for by Representative Paul Ryan’s (R-WI) budget proposal. It is also above the $1.043 trillion level for the current fiscal year called for by the law.

Public Law 112-155 – Sequestration Transparency Act of 2012:

On August 7, 2012, the President signed H.R. 5872, the Sequestration Transparency Act of 2012, into law as P.L. 112-155. Provisions require the President, within 30 days after the enactment of this Act, to submit to Congress a detailed report on the implementation of certain discretionary reductions (in security and non-security categories) and nonexempt direct spending reductions in the sequestration required in the Budget Control Act of 2011. The law requires the head of each executive agency, to provide upon request to the Director of the Office of Management and Budget any information at the program, project, and activity level necessary for the preparation of this report. This report is not binding and may not reflect final decisions, should the sequestration be implemented.

Congressional Briefings and Hearings:

On May 21, 2012, Senator Tom Harkin (D-IA) visited the NIH Clinical Center. Dr. Richard Hodes provided an update on Alzheimer’s disease research, Dr. Andrew Singleton (IRP) presented on the genetics of neurodegenerative disease, and Dr. Susan Resnick (IRP) discussed Alzheimer’s disease and the clinical applications of imaging. Representatives of NCI, NIMH, and NINDS also made presentations on a variety of health-related topics.

On June 21, 2012, Dr. Francis Collins, Director, NIH, testified before the House Energy and Commerce Subcommittee on Health (Joe Pitts, R-PA, chair), at a hearing entitled “The National Institutes of Health – A Review of Its Reforms, Priorities, and Progress.” The hearing reviewed the implementation of the 2006 NIH Reform Act, the progress of the National Center for Advancing Translational Sciences, and the determination of NIH funding and research priorities. Dr. Collins, who was the sole witness at this hearing, responded to several questions related to the implementation of the National Alzheimer’s Project Act.

Submitted by: Kate Nagy, National Institute on Aging